VACCINE VIOLENCE: THE VACCINES AND AUTISM STORY
vaccines and autism, vaccines and neurodevelopmental disorders, vaccine composition and chemicals, vaccine related baby deaths - updated 31 May 2016
When my first child was a baby and the health visitor was trying to convince me she absolutely needed the MMR vaccine I told her that I was against abortion and that one of my many reasons for NOT getting the MMR was that it was cultured using the cells of aborted fetuses.
She looked momentarily stunned and then said
"Oh, that must be wrong! You can't have got that right!?, you must be mistaken!?"
I told her I wasn't mistaken and that MMR was indeed cultured on the remains of human babies and she should go and look it up.
That conversation was an eye opener to me as I realised that many medical professionals, even the health visitors who give the vaccines, don't know what is in them or anything about their side-effects.
Her reaction was by no means isolated. Most people I mentioned it to were appalled, even people who were 'pro-choice'. To some the idea was so revolting they didn't believe me.
But aside from the ethical considerations and the grisly idea of consuming derivatives of human body parts, vaccines that use human fetal tissue in the harvesting of viruses have some serious health implications.
Vaccinated People Produce Antibodies to ALL ingredients in the Vaccines, Not just the Antigens
Vaccinated people can produce antibodies to all components of the shots and not just the antigens that they are supposed to be immunised against.
Researchers at the CDC suggested that some cases of anaphylaxis after MMR may be caused by allergy to gelatine, an animal bone product in the vaccine. They found that a proportion of children who'd had life-threatening allergic shock after the vaccine had antibodies to gelatine that they had developed after prior vaccines for DTaP etc.
Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
'Anaphylaxis after immunization, although rare, is serious and potentially life-threatening. Understanding risk factors for this reaction is therefore important. Gelatin is added to many vaccines as a heat stabilizer. Japanese researchers have demonstrated a strong association between immediate hypersensitivity reactions to measles, mumps, rubella, varicella, and Japanese encephalitis immunizations and subsequent detection of anti-gelatin immunoglobulin E (IgE) antibodies. They suggested that previous receipt by these patients of diphtheria-tetanus-acellular pertussis vaccines with trace amounts of gelatin was responsible for the sensitization.....
Anaphylactic reactions to MMR in the United States are rare. The reporting rate has the same order of magnitude as estimates from other countries. Almost one fourth of patients with reported anaphylaxis after MMR seem to have hypersensitivity to gelatin in the vaccine. They may be at higher risk of developing anaphylaxis to subsequent doses of other gelatin-containing vaccines. These people should seek an allergy evaluation before such immunization.'
A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
The 366 reported patients were categorized as follows: 34 with anaphylaxis, 76 with urticaria, 215 with nonurticarial generalized eruption, and 41 with local reactions only. In 206 patients from whom serum was available, IgE antibodies to gelatin were detected in 25 of 27 (93%) with anaphylaxis, 27 of 48 (56%) with urticaria, and 8 of 90 (9%) with a generalized eruption. None of a group of 41 patients with only local reactions at the injected site and none of a control group of 29 subjects with no adverse reaction had such antibodies. Among 202 patients for whom prior vaccine information was available, all had received DTaP vaccines. Among those for whom the prior DTaP vaccine could be determined to contain gelatin or be free of gelatin, 155 of 158 (98%) subjects had received gelatin-containing DTaP vaccines. This rate is higher than would be expected on the basis of the market share of gelatin-containing (vs gelatin-free) DTaP vaccines (75%). Furthermore, before 1993, when a trivalent measles, mumps, and rubella vaccine (with the same 0.2% gelatin content as the monovalent vaccines) was used and administered before DTaP vaccination, no reports of anaphylaxis to the measles, mumps, and rubella vaccine were received.
CONCLUSION:
Most anaphylactic reactions and some urticarial reactions to gelatin-containing measles, mumps, and rubella monovalent vaccines are associated with IgE-mediated gelatinallergy. DTaP immunization histories suggest that the gelatin-containing DTaP vaccine may have a causal relationship to the development of this gelatinallergy.
When Japan Took Gelatine out of Vaccines, Antibodies to Gelatine and Allergic Reactions Almost Ceased
Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy.
Abstract
From the early 1990s infants started to receive acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP) before live vaccines such as measles, rubella, and mumps vaccines, which contained gelatin as a stabilizer. Then, an increasing number of cases of anaphylactic/allergic reactions to those live vaccines were reported. Almost all these cases had a previous history of receiving three or four doses of DTaP containing gelatin.Anaphylactic/allergic reactions to live measles vaccine were analyzed using information obtained from the Reporting System, a retrospective study, as well as from the Monitoring System, a prospective study. Dramatic decreases in anaphylactic/allergic reactions to live measles vaccines were observed immediately after each manufacturer marketed gelatin-free or gelatin (hypo-allergic)-containing live measles vaccine, and since the end of 1998 reports on anaphylactic/allergic reactions to live measles vaccine have almost ceased.
So, What can Happen after Injection of Human Fetal Tissue?
Memories of the late 1980's and the BSE scandal and the infected cattle wobbling around, unable to walk because they ate meal from their own species - forced into cannabalism by unnatural factory farming methods, sprang to mind when I first read about the autism and human fetal tissue connection.
Researchers in Portugal found that children with autism had auto-antibodies to their own brain tissue even though their parents did not have the auto-antibodies and there was no evidence the problem was genetically inherited. The presence of these antibodies against self may in fact be because the children have produced antibodies against the trace amounts of human tissue in the vaccine.
Autoantibody repertoires to brain tissue in autism nuclear families
Abstract
The hypothesis of an immune dysfunction in autism spectrum disorders has previously been put forward without, however, compelling evidence of a direct relation to its etiology or pathogenesis. To further understand if autoimmunity could play a significant role in autism, we analyzed autoantibody repertoires to brain tissue extract in the plasma of 171 autism children, their parents, and 54 controls, by quantitative immunoblotting. Multiparametric analysis revealed significant differences between patients and controls, and showed that one single reactivity in Section 32 of the blot had the most power to discriminate between these samples. Family correlation coefficients and heritability estimates did not provide any evidence that this reactivity was genetically determined. While the molecular weight of the target protein suggested that it might be an isoform of Myelin Basic Protein (MBP), inhibition assays with human MBP argued against this hypothesis. The study evidences the widespread occurrence of autoreactivities to brain tissue in autism patients, which may represent the immune system's neuroprotective response to a previous brain injury occurred during neurodevelopment. The molecular identification of the target protein in Section 32 will contribute to the understanding of the role of immune responses against brain antigens in autistic patients.
Another recent study for the Journal of Public Health and Epidemiology suggested that the rise in autism has occurred with the introduction of human fetal tissue and retroviral contaminants into vaccines:
Impact of environmental factors on the prevalence of Autistic Disorder after 1979
'Rising autistic disorder prevalance is directly related to vaccines manufactured utilizing human fetal cells.'
People in favour of vaccines say that there is no fetal tissue in vaccines or that the orginal samples were used to harvest viruses in the 1960's and they don't have to use anymore tissue, but both these statements are inaccurate. Vaccine science is not an exact science and it is much cruder than most people realise. It is not possible to remove all traces of advantagious pathogens, DNA or culture tissue from the vaccines and some residual elements will remain. In fact there are viral and bacterial fragments, animal diseases, retroviruses from chicken embryo (another culture medium) that scientists weren't even aware was in the vaccine until they tested it. These are UNINTENDED ingredients.
(Journal of Virology, June 2010).
The Sound Choice Pharmaceutical Institute found that human fetal DNA fragments were retained in vaccine samples:
'This study demonstrates that primitive short DNA fragments (50-300 bp) are spontaneously taken up by HFF-1, U937 and NCCIT cells and inserted into the genome of the monocytic leukemia cell line U937. Hence, vaccines containing residual HERVK and human fetal DNA fragments may contribute to the genomic instability observed in ASD.'
(Spontaneous Integration of Human DNA Fragments into Host Genome')
Secondly, new samples of aborted fetal tissue are being taken and new cell lines developed. The PER.C6 cell line was made in 1995 using the eye tissue of an aborted 21 week old baby and an 18 week old baby that the mother aborted because she didn't know who its father was. The retinal tissue from both these babies was used to culture viruses for flu and TB vaccines as well as experimental HIV, maleria, rabies and cancer vaccines.
(FDA Docket).
As scientists are fully aware of the problems that animal growth mediums can present, human fetal tissue, or 'human diploid cells' are a more attractive choice to some.
